Insilico's Potential Best-in-Class AI Drug for Sought-After Cancer Target -
InSilico Medicine, a clinical-stage company utilizing generative artificial intelligence (AI) for drug discovery, reveals the development of
Stay updated with breaking news from Feng Ren. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
InSilico Medicine, a clinical-stage company utilizing generative artificial intelligence (AI) for drug discovery, reveals the development of
Insilico Medicine ("Insilico"), a generative artificial intelligence (AI)-driven clinical-stage drug discovery company, today announced the nomination of ISM8001, a novel molecule targeting FGFR2/3 for the treatment of tissue-agnostic solid tumors bringing the total number of PCCs nominated in 2023 to six.
After having natural human-like conversations with humans, AI could potentially be treating them medically, as the first drug fully generated by artificial intelligence has now entered clinical...
Washington DC (UPI) Jul 2, 2023 - The first dose of a drug developed by artificial intelligence has been delivered to its first patient.
In a first, a drug discovered and designed using artificial intelligence (AI) for the treatment of idiopathic pulmonary fibrosis (IPF), a chronic disease that causes scarring in the lungs, has entered human clinical trials.Hong Kong-based ...